ATE386021T1 - Verfahren zur herstellung des piperidinderivats fexofenadin - Google Patents

Verfahren zur herstellung des piperidinderivats fexofenadin

Info

Publication number
ATE386021T1
ATE386021T1 AT02754657T AT02754657T ATE386021T1 AT E386021 T1 ATE386021 T1 AT E386021T1 AT 02754657 T AT02754657 T AT 02754657T AT 02754657 T AT02754657 T AT 02754657T AT E386021 T1 ATE386021 T1 AT E386021T1
Authority
AT
Austria
Prior art keywords
fexofenadine
producing
piperidine derivative
piperidine
derivative
Prior art date
Application number
AT02754657T
Other languages
English (en)
Inventor
Collin Schroeder
Ryan Huddleston
Richard Charles
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of ATE386021T1 publication Critical patent/ATE386021T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02754657T 2001-06-15 2002-06-12 Verfahren zur herstellung des piperidinderivats fexofenadin ATE386021T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29839701P 2001-06-15 2001-06-15

Publications (1)

Publication Number Publication Date
ATE386021T1 true ATE386021T1 (de) 2008-03-15

Family

ID=23150325

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02754657T ATE386021T1 (de) 2001-06-15 2002-06-12 Verfahren zur herstellung des piperidinderivats fexofenadin

Country Status (23)

Country Link
US (2) US6743941B2 (de)
EP (1) EP1401816B1 (de)
JP (1) JP4344230B2 (de)
KR (1) KR100903285B1 (de)
CN (1) CN1229347C (de)
AR (1) AR037005A1 (de)
AT (1) ATE386021T1 (de)
AU (1) AU2002320847B2 (de)
BR (1) BR0210410A (de)
CA (1) CA2450313C (de)
DE (1) DE60225008T2 (de)
DK (1) DK1401816T3 (de)
ES (1) ES2298384T3 (de)
HK (1) HK1063795A1 (de)
HU (1) HUP0401125A2 (de)
IL (2) IL159304A0 (de)
MX (1) MXPA03010960A (de)
NO (1) NO20035572L (de)
NZ (1) NZ530153A (de)
PL (1) PL364369A1 (de)
PT (1) PT1401816E (de)
WO (1) WO2002102776A1 (de)
ZA (1) ZA200308697B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7498345B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US7498443B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of carebastine
CN100453522C (zh) * 2005-01-26 2009-01-21 中国科学技术大学 4-[4-(1-乙氧基酰基-1-甲基乙基苯)]-4-氧代丁酸的制备方法
WO2007135693A2 (en) * 2006-05-18 2007-11-29 Ind-Swift Laboratories Limited Intermediates useful for the preparation of antihistaminic piperidine derivative
ITMI20061492A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
ITMI20061491A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
CN102070490B (zh) * 2009-11-21 2014-07-30 浙江华海药业股份有限公司 一种非索非那定中间体2-(4-(4-羟基丁酰基)苯基)-2-甲基丙氰的制备方法
CN102070570A (zh) * 2009-11-21 2011-05-25 浙江华海药业股份有限公司 一种非索非那定中间体2-甲基-2(4-(2-氧代四氢呋喃-3-羰基)苯基)丙氰及其盐的制备方法
RU2017139727A (ru) 2015-06-15 2019-07-16 АСАНА БАЙОСАЙЕНСИЗ, ЭлЭлСи Гетероциклические ингибиторы erk1 и erk2 и их применение для лечения злокачественного новообразования
CN104876853B (zh) * 2015-06-17 2017-06-16 苏州卫生职业技术学院 盐酸非索非那定的合成方法
DK3365327T3 (da) 2015-10-22 2020-02-24 Sanofi Aventis Deutschland Fremgangsmåde til fremstilling af fexofenadin og mellemprodukter, der anvendes deri
US20230027072A1 (en) 2019-10-28 2023-01-26 Asana Biosciences, Llc Improved methods, kits, compositions and dosing regimens for the use of heterocyclic inhibitors of erk1 and erk2

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2946809A1 (de) * 1979-11-20 1981-06-11 A. Nattermann & Cie GmbH, 5000 Köln 4-phenyl-4-oxo-buttersaeuren, deren salze und ester, verfahren zu deren herstellung und diese enthaltende arzneimittel
IT1200123B (it) 1985-09-27 1989-01-05 Ind Chimica Srl Procedimento per la preparazione di alfa-(p-terbutilfenil)-4-(idrossidifenilmetil)-1-piperidinobutanolo
EP0347123A3 (de) 1988-06-17 1991-07-03 Fisons Corporation Dibenzo-cycloheptenyl-, -cycloheptyl- und -oxepinylamine mit antihistaminischer Aktivität
IT1249684B (it) 1991-07-19 1995-03-09 Sorin Biomedica Spa Epitopi della proteina env del virus dell'epatite c.
WO1993021156A1 (en) * 1992-04-10 1993-10-28 Merrell Dow Pharmaceuticals Inc. 4-diphenylmethyl piperidine derivatives and process for their preparation
AU670004B2 (en) 1993-06-24 1996-06-27 Albany Molecular Research, Inc. Piperidine derivatives and process for their production

Also Published As

Publication number Publication date
DE60225008T2 (de) 2009-01-29
BR0210410A (pt) 2004-08-17
HK1063795A1 (en) 2005-01-14
AR037005A1 (es) 2004-10-20
US20030105329A1 (en) 2003-06-05
KR100903285B1 (ko) 2009-06-17
US6743941B2 (en) 2004-06-01
KR20040010720A (ko) 2004-01-31
JP2005502603A (ja) 2005-01-27
NO20035572L (no) 2004-02-16
US20040198983A1 (en) 2004-10-07
CA2450313C (en) 2010-08-10
AU2002320847B2 (en) 2007-09-20
IL159304A0 (en) 2004-06-01
NZ530153A (en) 2005-07-29
HUP0401125A2 (hu) 2004-09-28
DK1401816T3 (da) 2008-06-09
CA2450313A1 (en) 2002-12-27
CN1229347C (zh) 2005-11-30
ES2298384T3 (es) 2008-05-16
PL364369A1 (en) 2004-12-13
DE60225008D1 (de) 2008-03-27
IL159304A (en) 2010-02-17
EP1401816A1 (de) 2004-03-31
JP4344230B2 (ja) 2009-10-14
MXPA03010960A (es) 2004-02-27
EP1401816B1 (de) 2008-02-13
US7235665B2 (en) 2007-06-26
CN1516689A (zh) 2004-07-28
WO2002102776A1 (en) 2002-12-27
NO20035572D0 (no) 2003-12-12
PT1401816E (pt) 2008-04-08
ZA200308697B (en) 2004-09-03

Similar Documents

Publication Publication Date Title
DE60221399D1 (de) Verfahren zur herstellung von mitteldistillaten
ATE403641T1 (de) Verfahren zur herstellung von o- desmethylvenlafaxin
DE60107450D1 (de) Verfahren zur herstellung von fluoroelastomeren
ATE386736T1 (de) Verfahren zur herstellung von benzimidazol-2-yl - chinolinonderivaten
ATE353322T1 (de) Verfahren zur herstellung von 2- (chinoxalin-5- ylsulfonylamino) -benzamid-verbindungen
DE60238696D1 (de) Verfahren zur herstellung von hundefutter
ATE300520T1 (de) Verfahren zur herstellung amlodipinmaleat
DE60230908D1 (de) Verfahren zur herstellung von polyarylenethern
DE60317690D1 (de) Verfahren zur herstellung von valsartan
ATE249417T1 (de) Verfahren zur herstellung von l- phenylephrinhydrochlorid
ATE315099T1 (de) Verfahren zur herstellung von tagatose
ATE386021T1 (de) Verfahren zur herstellung des piperidinderivats fexofenadin
ATE296287T1 (de) Verfahren zur herstellung von repaglinide
ATE284875T1 (de) Verfahren zur herstellung von mesylaten von piperazinderivaten
DE50102444D1 (de) Verfahren zur herstellung von isocyanatoorganosilanen
ATE441662T1 (de) Verfahren zur herstellung von echinocandinderivaten
ATE287870T1 (de) Verfahren zur herstellung von phenethylamin- derivaten
DE50111560D1 (de) Verfahren zur herstellung von guerbetalkoholen
DE50303611D1 (de) Verfahren zur herstellung von polyisobuten
DE60210911D1 (de) Verfahren zur Herstellung von dehnungserfassenden Vorrichtungen
ATE273315T1 (de) Verfahren zur herstellung von n- phosphonomethyliminodiessigsäure
DE60103173D1 (de) Verfahren zur herstellung von 3-amino-2-chlor-4-methylpyridin
DE50200870D1 (de) Verfahren zur herstellung von hydroxyalkylpolysiloxanen
ATE402138T1 (de) Verfahren zur herstellung von 2- aminoindanderivaten
DE60105991D1 (de) Verfahren zur herstellung von 6-aminocapronamid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1401816

Country of ref document: EP